EVP, Drug Development
Thu, Jan 13, 2022
Jan 13
2,012 shares @ $8.30
Decreased holdings by -22.20%
6th largest trade (out of 63)
Cluster Buy
Trade made by an officer
Part of a cluster of 5 transactions by 3 insiders
Price 34% below 200-day moving average